Continuous infusion of prostacyclin decreases plasma levels of t-PA and PAI-1 in primary pulmonary hypertension.
D000328:Adult; D004730:Endothelium, Vascular / Q000378:metabolism / Q000473:pathology; D011464:Epoprostenol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000097:blood / Q000188:drug therapy*; D008297:Male; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood
D017395:Plasminogen Activator Inhibitor 1; D011464:Epoprostenol